MAPT and early-onset autosomal dominant Alzheimer disease: Overall, these data are helpful for further investigating the molecular mechanisms that underlie the pathogenesis of some amyloidogenic disorders, such as prion diseases or Alzheimer’s disease, and the involvement of Tau protein as a co-actor of the pathogenic processes.